Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)

Head and neck squamous cell carcinoma (HNSCC) is one of the most common and aggressive types of human cancers worldwide. Nearly a half of HNSCC patients experience recurrence within five years of treatment and develop resistance to chemotherapy. Thus, there is an urgent clinical need to develop safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fugui, Li, Yong, Zhang, Hongmei, Huang, Enyi, Gao, Lina, Luo, Wenping, Wei, Qiang, Fan, Jiaming, Song, Dongzhe, Liao, Junyi, Zou, Yulong, Liu, Feng, Liu, Jianxiang, Huang, Jiayi, Guo, Dan, Ma, Chao, Hu, Xue, Li, Li, Qu, Xiangyang, Chen, Liqun, Yu, Xinyi, Zhang, Zhicai, Wu, Tingting, Luu, Hue H., Haydon, Rex C., Song, Jinlin, He, Tong-Chuan, Ji, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355070/
https://www.ncbi.nlm.nih.gov/pubmed/28099902
http://dx.doi.org/10.18632/oncotarget.14673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355070/
https://www.ncbi.nlm.nih.gov/pubmed/28099902
http://dx.doi.org/10.18632/oncotarget.14673

Ejemplares similares